Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History VXRT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics VXRT

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 09.11.2012

Vaxart Inc

VXRT
Current price
0.35 USD +0.047 USD (+15.63%)
Last closed 0.32 USD
Company vaxart.com
ISIN US92243A2006
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 97 451 224 USD
Yield for 12 month -48.56 %
1Y
3Y
5Y
10Y
15Y
VXRT
21.11.2021 - 28.11.2021

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California. Address: 170 Harbor Way, South San Francisco, CA, United States, 94080

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.67 USD

P/E Ratio

Dividend Yield

Financials VXRT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures VXRT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+28 700 000 USD

Last Year

+7 379 000 USD

Current Quarter

+20 876 000 USD

Last Quarter

+15 185 000 USD

Current Year

+28 700 000 USD

Last Year

+7 379 000 USD

Current Quarter

+20 876 000 USD

Last Quarter

+15 185 000 USD
EBITDA -48 238 000 USD
Operating Margin TTM -71.54 %
Price to Earnings
Return On Assets TTM -28.90 %
PEG Ratio
Return On Equity TTM -114.74 %
Wall Street Target Price 4.67 USD
Revenue TTM 47 395 000 USD
Book Value 0.20 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 857.20 %
Dividend Yield
Gross Profit TTM -38 549 000 USD
Earnings per share -0.26 USD
Diluted Eps TTM -0.26 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -122.63 %

Stock Valuation VXRT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 42.74
Enterprise Value Revenue 1.58
Price Sales TTM 2.06
Enterprise Value EBITDA -0.17
Price Book MRQ 2.19

Technical Indicators VXRT

For 52 Weeks

0.29 USD 1.07 USD
50 Day MA 0.46 USD
Shares Short Prior Month 14 675 190
200 Day MA 0.60 USD
Short Ratio 2.61
Shares Short 21 173 323
Short Percent 9.40 %